Agenda

9:00 AM

Session chair: Melanie Brickman Borchard, PhD, MSc, The New York Academy of Sciences

Nicholas Dirks, PhD, The New York Academy of Sciences  

Jie Zhang, PhD, The Shanghai Association for Science and Technology  

Sheng Xu, PhD, Stanford University  

9:15 AM 

Welcome Video: Nobel Laureate, James P. Allison, PhD, MD, The University of Texas MD Anderson Cancer Center 

9:20 AM  To Be Announced  

9:50 AM  How Lymphoma Contributes to Advanced Cell and Immune-Based Therapies 

Wei-Li Zhao, MD, PhD, Shanghai Institute of Hematology, Shanghai Ruijin Hospital 

10:55 AM    Immunotherapy in Lung Cancer: What Is New in 2026?  

Caicun Zhou, MD, PhD Shanghai East Hospital and Tongji University  

11:25 AM    Mismatch Repair Deficient Tumor Interception by Neoantigen Surveillance

Nina Bhardwaj, MD, PhD, Icahn School of Medicine at Mount Sinai  

1:00 PM To Be Announced  

1:30 PM To Be Announced 

Qiang Gao, MD, PhD Zhongshan Hospital and Fudan University

2:35 PM To Be Announced 

Huaqiang “Eric” Xu, PhD, Ruijin Hospital, Shanghai Jiao Tong University, and the Chinese Academy of Sciences  

3:05 PM Targeted Cellular Micropharmacies and Micropharmacists  

David Sheinberg, MD, PhD, Memorial Sloan Kettering Cancer Center  

3:35 PM

Moderator:  

Taha Merghoub, PhD, Weill Cornell Medicine 

Panelists 

Michelle Krogsgaard, PhD, NYU Grossman School of Medicine 

Jia Fan, MD, PhD Zhongshan Hospital and Fudan University 

Guang Ning, MD, PhD, Ruijin Hospital and Shanghai Jiao Tong University School of Medicine --  

Mei Tian, MD, PhD, Fudan University and Huashan Hospital

Jiong Wu, MD, PhD Fudan University Shanghai Cancer Center  

Melanie Brickman Borchard, PhD, MSc, The New York Academy of Sciences